Incidence and outcomes of nephrotic syndrome among Canadian-born and immigrant children
Background Nephrotic syndrome (NS) is a common childhood kidney disease, with higher incidence among Asian and Black children. Immigrants to Canada are at increased risk of immune-mediated inflammatory diseases. Our aim was to determine if NS incidence and outcomes vary by immigration status. Methods We included children (6 months-18 years) with NS enrolled in INSIGHT, a prospective cohort in the Greater Toronto and Hamilton Area, Canada. The primary exposure was childhood immigration status. NS incidence rate ratios (IRRs) were calculated by Poisson regression, using Statistics Canada Census data to determine the population at-risk. We evaluated associations between childhood immigration status and steroid resistance, steroid-sparing medication use, and relapse patterns using multivariable regression. Results Among 712 children with NS, 90 (13%) immigrated to Canada prior to diagnosis, 50 (7%) immigrated after diagnosis, and 572 (80%) were Canadian-born. NS incidence was 3.7 per 100,000 person-years (95% CI 3.0 to 4.4) among immigrants and 2.0 (95% CI 1.8 to 2.2) among Canadian-born children (IRR 1.84, 95% CI 1.49 to 2.24, P < 0.001). NS incidence was higher among South Asian (IRR 1.47, 95% CI 1.10 to 1.94) and African or Caribbean children (IRR 2.61, 95% CI 1.44 to 4.49) that were immigrants, compared with Canadian-born. There were no significant differences in the risk of steroid resistance, steroid-sparing medication use, frequent relapses or steroid dependence, or relapse rate between immigrants vs. Canadian-born children. Interpretation Immigrant children had higher observed incidence of NS when compared to Canadian-born children, although disease outcomes are similar. This suggests that factors associated with disease occurrence and subsequent outcomes may differ. Study registration ClinicalTrials.gov identifier NCT1605266
Authors
- Rahul Chanchlani (ORCID: https://orcid.org/0000-0001-9366-3118)
- Jovanka Z. Vasilevska-Ristovska (ORCID: https://orcid.org/0000-0002-1465-2523)
- Cal Robinson (ORCID: https://orcid.org/0000-0002-2223-0646)
- Chia Wei Teoh (ORCID: https://orcid.org/0000-0002-5994-0799)
- Damien Gerard Noone (ORCID: https://orcid.org/0000-0003-3385-6174)
- Josefina A. Brooke
- Ashlene Maree McKay (ORCID: https://orcid.org/0000-0002-8880-1886)
- Rachel Jane Pearl
- Mackenzie Garner (ORCID: https://orcid.org/0009-0005-5472-7920)
- Valentina Bruno (ORCID: https://orcid.org/0000-0001-7052-1539)
- Rulan Savita Parekh (ORCID: https://orcid.org/0000-0001-6313-5752)
- Nowrin F. Aman
- Christoph P. B. Licht (ORCID: https://orcid.org/0000-0003-4168-3277)
- Tanay Joshi (ORCID: https://orcid.org/0009-0005-0579-772X)
- Nithiakishna Selvathesan (ORCID: https://orcid.org/0000-0001-7780-9260)
- Tonny Hue Minh Banh (ORCID: https://orcid.org/0000-0002-5857-7641)
- Vaneet Dhillon (ORCID: https://orcid.org/0009-0001-6345-1584)
- Seetha Radhakrishnan (ORCID: https://orcid.org/0000-0003-1102-7623)
- Keisha Rasool
- Sophia Gorgiev
- Kristen Vanos
Institutions
- University of Alberta (CA)
- University of Toronto (CA)
- Hospital for Sick Children (CA)
- Women's College Hospital (CA)
- McMaster Children's Hospital (CA)
- University of Alberta Hospital (CA)
- William Osler Health System (CA)
- McMaster University (CA)
Publication Details
- Journal
- Paediatrics & Child Health
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1093/pch/pxag105
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00